Natalizumab and progressive multifocal leukoencephalopathy

被引：42

作者：

Adelman, B ^{[1
]}

Sandrock, A ^{[1
]}

Panzara, MA ^{[1
]}

机构：

[1] Biogen Idec Inc, Cambridge, MA 02142 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 04期

关键词：

D O I：

10.1056/NEJMc055235

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：432 / 433

页数：2

相关论文

共 5 条

[1]

The lower limit of sensitivity of the quantitative PCR assay is 4000 copies/mL, but it reliably detects 25,000 copies/mL and absolutely detects 6 log10 copies/mL. (vol 5, pg 839, 2005) [J].

Brennan, DC ;

Agha, I ;

Bohl, DL .

AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (04) :839-839

[2]

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction [J].

Brennan, DC ;

Agha, I ;

Bohl, DL ;

Schnitzler, MA ;

Hardinger, HL ;

Lockwood, M ;

Torrence, S ;

Schuessler, R ;

Roby, T ;

Gaudreault-Keener, M ;

Storch, GA .

AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) :582-594

[3]

Brief report - Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis [J].

Kleinschmidt-DeMasters, BK ;

Tyler, KL .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04) :369-374

[4]

Brief report - Progressive multifocal leukoencephalopathy in a patient treated with natalizumab [J].

Langer-Gould, A ;

Atlas, SW ;

Green, AJ ;

Bollen, AW ;

Pelletier, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04) :375-381

[5]

Brief report - Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease [J].

Van Assche, G ;

Van Ranst, M ;

Sciot, R ;

Dubois, B ;

Vermeire, S ;

Noman, M ;

Verbeeck, J ;

Geboes, K ;

Robberecht, W ;

Rutgeerts, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04) :362-368